Lifetime Measurements of Low-Spin Negative-Parity Levels in \u3csup\u3e160\u3c/sup\u3eGd

160Gd(n,n′γ) experiments were performed with accelerator-produced monoenergetic neutrons. Excitation functions at neutron energies from 1.5 to 2.8 MeV aided in the placement of γ rays in the level scheme and angular distributions at three neutron energies resulted in the determination of 28 excited-level lifetimes or limits in 160Gd, including the lifetimes of several negative-parity levels attributed to octupole vibrations

Collectivity of 0\u3csup\u3e+\u3c/sup\u3e States in \u3csup\u3e160\u3c/sup\u3eGd

Excited 0+ states in 160Gd have been examined with the (n,n′γ) reaction at incident neutron energies up to 2.8 MeV. Gamma-ray excitation functions and angular distribution measurements allow the confirmation of the existence of 0+ states at 1379.70 keV and 1558.30 keV, but we reject the assignments of additional previously suggested 0+ candidates. Limits on the level lifetimes of the observed 0+ states permit an evaluation of the collectivity of these states

Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck

CD9 is a transmembrane protein that has been implicated in cell adhesion, motility and proliferation, and numerous studies have demonstrated the prognostic value of its expression in different solid tumours. The purpose of this study is to determine the predictive value of CD9 in squamous cell carcinoma (SCC) of the head and neck. A total of 153 cases were examined for CD9 expression using immunohistochemistry applied on formalin-fixed, paraffin-embedded tissue. Cases were stratified in two categories depending on CD9 expression, as positive (>/=50% positive cells) or reduced (<50%). In all, 108 cases were positive for CD9 (85 cases with membranous, and 23 with both membranous and cytoplasmic staining) and 45 reduced expression. Reduced CD9 expression was significantly associated with high grade (P=0.0007) and lower disease-free survival (DFS) (P=0.017). The latter retained its significance in the multivariate analysis. When the 23 cases with both membranous and cytoplasmic patterns were studied as a separate subgroup, there were significant associations between CD9 expression and tumour grade (P=0.025) (95% CI 11-68), tumour stage (P=0.08) (95% CI 3.5-86) and the occurrence of any failure (P=0.083) (95% CI -1.7-57). Immunohistochemical CD9 expression proved to be an independent prognostic factor in SCC of the head and neck, and it may detect patients at a high risk of recurrence. In addition, the cytoplasmic pattern seems to have an even more significant value. However, this finding is limited to the small number of cases with this pattern

Status of 48Ca double beta decay search and its future prospect in CANDLES

CANDLES(CAlcium fluoride for the study of Neutrinos and Dark matters by Low Energy Spectrometer) is the experiment to search for the neutrino-less double beta decay(0vββ) of 48Ca with CaF2 scintillator. 48Ca has the highest Qββ-value (4.3 MeV) among all isotope candidates for 0vββ. It enables us to measure signals with very low background condition. After rejection analysis with 131 days × 86 kg data for background events from radioactive contaminations in the CaF2 scintillators, no events are observed in the Qββ-value region. As a result, the 0vββ half-life of 48Ca is greater than 6.2 × 1022 yr (90% confidence level). For further high sensitive measurement of 48Ca 0vββ search, we have been developing the 48Ca enrichment and CaF2 scintillating bolometer techniques. In this paper, the latest result for CANDLES and the status of scintillating bolometer development are described

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma

<p>Abstract</p> <p>Background</p> <p>The aim of this study was to clarify the clinical significance of TM4SF members CD9, CD63 and CD82 in human gastric carcinoma.</p> <p>Methods</p> <p>By employing RT-PCR and immunohistochemistry, we studied the expression of CD9, CD63 and CD82 in 49 paired tissue specimens of normal gastric mucosa and carcinoma. All tissues were obtained from patients who underwent curative surgery.</p> <p>Results</p> <p>All normal gastric epithelium and gastric ulcer tissues strongly expressed transcripts and proteins of CD9, CD63 and CD82 as compared with corresponding controls. We found a significant correlation between CD63 mRNA level and different pM statuses (P = 0.036). Carcinomas in M0 stage revealed a stronger expression of CD63 than carcinomas in M1 stage. Expression of CD9 protein was found significantly stronger in pN0, pM0 than in advanced pN stages (P = 0.03), pM1 (P = 0.013), respectively. We found the relationship between CD63 expression, gender (p = 0.09) and nodal status (p = 0.028), respectively. Additionally, advanced and metastasized tumor tissues revealed significantly down-regulated CD82 protein expression (p = 0.033 and p = 0, respectively), which correlated with the tumor pTNM stage (p = 0.001).</p> <p>Conclusion</p> <p>The reduction of CD9, CD63 and CD82 expression are indicators for the metastatic potential of gastric carcinoma cells. Unlike their expression in other tumor types, the constitutive expression of CD63 may indicate that this factor does play a direct role in human gastric carcinogenesis.</p